ASXL1 or ASXL2 truncating mutations, which inhibit myeloid differentiation and induce a myelodysplastic syndrome-like disease in mice [108,109], have been described in ~35% of t(8;21) while are absent in inv(16) AML [15,110,111]. The gene discussed is ASXL2; the disease is acute myeloid leukemia.